Skip to main content
. 2023 Apr 3;78(10):983–989. doi: 10.1136/thorax-2022-219382

Figure 6.

Figure 6

The on-treatment times per quintile for the LABA/LAMA (umeclidinium/vilanterol, UMEC/VI) and triple therapy (fluticasone furoate/umeclidinium/vilanterol, FF/UMEC/VI) arms in IMPACT. IMPACT, InforMing the PAthway of COPD Treatment.